About

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Medical Information aims to empower the healthcare community to make informed decisions about our medicines, enabling better outcomes for patients.

466-GB-2200012 - Date of Preparation March 2022

Address

BMS House
Uxbridge Business Park
Sanderson Road
Uxbridge
Middlesex
UB8 1DH

Contact details

Medical Information phone number
+44-(0)0800 731 1736

Hours of operation
Available 24 hours a day, 365 days a year

Medical Information website
https://www.bmsmedinfo.co.uk/

Medical Information email
medical.information@bms.com

Click to chat
https://www.bmsmedinfo.co.uk/

Adverse events and product complaints

+44-(0)0800 731 1736

Adverse event phone number
+44-(0)0800 731 1736

Adverse event email
medical.information@bms.com

Company website
https://www.bms.com/gb

BMS products

Medicinal products marked withare subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

ABRAXANE®
(nab-paclitaxel)

EMPLICITI®
(elotuzumab)

IMNOVID®
(pomalidomide)

INREBIC®
(fedratinib)

OPDIVO®
(nivolumab)

OPDIVO® + YERVOY® Regimen
(nivolumab, ipilimumab)

REVLIMID®
(lenalidomide)

THALIDOMIDE CELGENE®
(thalidomide)

VIDAZA®
(azacitidine)

ZEPOSIA®
(ozanimod)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Last updated: 02/03/2023